Lumos Pharma Inc

NASDAQ:LUMO  
1.65
-0.12 (-6.78%)
4:57:45 PM EDT: $1.70 +0.05 (+3.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)12.48M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.27 Million
Adjusted EPS-$1.17
See more estimates
10-Day MA$1.96
50-Day MA$2.43
200-Day MA$2.94
See more pivots

Lumos Pharma Inc Stock, NASDAQ:LUMO

4200 Marathon Boulevard, Suite 200, Austin, Texas 78756
United States of America
Phone: +1.512.215.2630
Number of Employees: 33

Description

Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.